For example, thymosin alpha 1 (which shares similarities with IL-7) recently demonstrated promising results in COVID-19 patients.10 The present IL-7 effects, despite unfavorable outcome, appear consistent in terms of immunological recovery as, to date, such a rapid rise in standard immune parameters has not been observed in long-standing COVID-19 patients. This evidence concerns the gene IL7 and COVID-19.